ARCHIVES

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Committee Unblinds Phase III Zytiga Study

March 30, 2012

Cancer Research Emphasis Grants (CREG) Offered As A New Way To Fund Contract Research Efforts

November 23, 1974

UICC Seeks Nominations for Mucio Athayde Prize.

January 7, 2000

Campus-Dweller Rabson Finds Comfort In NIH Security.

December 14, 2001

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003

NCI To Offer New Grants In Preventative Oncology -Epidemiology, Biostatistics

October 26, 1979